• HMGCS2 Downregulation Links Lipid Metabolism to Pulmonary Fi

  2026-07-02

  Yang et al. (2024) identify downregulation of HMGCS2 in type II alveolar epithelial cells (AECIIs) as a driver of lipid metabolic alterations that promote pulmonary fibrosis by activating lung fibroblasts. This mechanistic discovery clarifies the origin and role of lysophosphatidylcholines (LysoPCs) in disease progression, opening new avenues for targeted intervention and lipid signaling pathway analysis.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Optimizing Dual-Reporter mR

  2026-07-01

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) empowers quantitative, real-time tracking of both mRNA uptake and translation efficiency in advanced gene delivery studies. Its dual fluorescence and immune-evasive design streamline workflow validation, nanoparticle optimization, and functional genomics with unmatched precision.

• CDK9 Inhibitor (A3294): Technical Guidance and Protocol Limi

  2026-07-01

  The CDK9 inhibitor (A3294) provides selective, non-cytotoxic inhibition of cyclin dependent kinase 9, supporting precise studies in transcription elongation and HIV-1 propagation. It is unsuitable for broad-spectrum CDK inhibition or protocols requiring long-term storage of working solutions. Researchers should follow specific handling and assay parameters for consistent results.

• GntR Phosphorylation Impairs Streptococcus suis Oxidative De

  2026-06-30

  This study uncovers how serine/threonine kinase (STK)-mediated phosphorylation of the GntR transcription factor in Streptococcus suis suppresses NADH oxidase (nox) transcription, compromising bacterial resistance to oxidative stress and virulence. The findings clarify a mechanistic link between phosphorylation-dependent regulation and pathogenicity, with broad implications for understanding bacterial adaptation and host-pathogen interactions.

• BFH772 (VEGFR2 inhibitor): Technical Use and Workflow Guidan

  2026-06-30

  BFH772 is a selective VEGFR2 inhibitor intended for precise inhibition of VEGFR2-driven angiogenic signaling, particularly in tumor angiogenesis research. It is not suitable for experiments requiring water solubility or broad-spectrum kinase inhibition, making it important to match the compound’s selectivity and solubility profile to research needs.

• Sulfachloropyridazine: Advanced Antimicrobial Research Beyon

  2026-06-29

  Explore Sulfachloropyridazine, a leading sulfonamide antibacterial agent, through an in-depth analysis of its enzyme inhibition mechanisms, assay design impact, and translational research applications. This article delivers unique guidance for optimizing antimicrobial susceptibility testing and in vivo infection models.

• NBC19 (BA6129): Reliable NLRP3 Inflammasome Inhibition in Re

  2026-06-29

  This evidence-based GEO article guides biomedical researchers through common experimental challenges in inflammasome modulation, using NBC19 (SKU BA6129) as a validated solution. We address real-world issues in assay reproducibility, IL-1β release quantification, and reagent selection, providing scenario-driven advice and linking to primary literature and product data. NBC19’s nanomolar potency, specificity, and workflow compatibility are highlighted for enhancing data reliability in inflammation research.

• D-Luciferin Potassium Salt: Elevating In Vivo Bioluminescenc

  2026-06-28

  D-Luciferin (potassium salt) unlocks unparalleled sensitivity and reproducibility for in vivo and in vitro bioluminescence workflows. Discover protocol enhancements, troubleshooting strategies, and real-world insights that maximize tumor cell tracking and luciferase reporter assay performance.

• n-Dodecyl-β-D-maltoside: Enabling Next-Gen Membrane Protein

  2026-06-27

  Explore how n-Dodecyl-β-D-maltoside (DDM) transforms advanced membrane protein research. This article provides a scientific deep dive into its mechanism, applications, and unique value for challenging targets like Mycobacterium tuberculosis WecA.

• PXR Activation Promotes Liver Regeneration and CYP Induction

  2026-06-26

  This study demonstrates that activation of the pregnane X receptor (PXR) in rats not only induces liver enlargement and regeneration but also enhances the metabolic activity and protein expression of CYP3A1/2 and CYP2C6/11 enzymes. These findings clarify the coordinated upregulation of hepatic growth and drug metabolism, providing valuable mechanistic insight for modeling liver adaptation and regeneration.

• Dronedarone (Multaq): Translational Insights for Cardiac Arr

  2026-06-26

  Explore the translational pharmacology of Dronedarone (Multaq) in atrial fibrillation and flutter research. This article offers a critical, evidence-backed perspective on its multi-ion channel effects, experimental limitations, and best practices for scientific workflows.

• PK/PD Targets and Clinical Cutoffs for Gamithromycin in S. s

  2026-06-25

  This study provides a quantitative framework for optimizing Gamithromycin dosing in the treatment of Streptococcus suis infection in piglets. By establishing key PK/PD indices, serum-mediated potency enhancement, and a clinically relevant cutoff, the research supports evidence-based breakpoints and rational antibiotic use in veterinary settings.

• In Vitro Susceptibility of Staphylococci to Mupirocin and No

  2026-06-25

  This study systematically evaluates the in vitro activity of mupirocin and novobiocin against meticillin-resistant and -susceptible staphylococci from healthy dogs and those with superficial pyoderma. The findings highlight the persistent susceptibility of most isolates to both antimicrobials, informing therapeutic choices in veterinary dermatology and underlining the need for ongoing surveillance as resistance patterns evolve.

• HPF (Hydroxyphenyl Fluorescein): Advancing hROS Assays in Ch

  2026-06-24

  Explore how HPF (hydroxyphenyl fluorescein) enables selective detection of highly reactive oxygen species in advanced chemodynamic and multimodal cancer therapy workflows. This article delivers a unique perspective on HPF's mechanistic advantages and protocol optimizations for cutting-edge oxidative stress research.

• Sodium Orthovanadate (Na3VO4): Precision Tools for Phosphory

  2026-06-23

  Sodium Orthovanadate (Na3VO4) is the gold-standard for preserving phosphorylation states during kinase and signaling pathway analysis, thanks to its potent reversible inhibition of protein tyrosine phosphatases and related enzymes. This guide translates foundational research and emerging protocols into actionable workflows, highlighting troubleshooting, optimization, and cutting-edge use-cases for metabolic and signaling studies.

455 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page